Encompass Health (NYSE: EHC) director credited 85 RSUs from dividend

Rhea-AI Filing Summary

Encompass Health Corp director Joan E. Herman reported an automatic acquisition of 85 shares of common stock in the form of restricted stock units (RSUs). These RSUs were credited under outstanding award agreements in connection with the July 15, 2026 common stock dividend of $0.19 per share, when the stock’s closing price was $109.88. Following this dividend-equivalent RSU award, Herman directly holds 49,643 shares of Encompass Health common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider HERMAN JOAN E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	85	$0.00	--

Holdings After Transaction: Encompass Health Common Stock — 49,643 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

RSUs Awarded: 85 shares Dividend per Share: $0.19 per share Closing Share Price: $109.88 +1 more

4 metrics

RSUs Awarded 85 shares Restricted stock units credited to Joan E. Herman on July 15, 2026

Dividend per Share $0.19 per share Common stock dividend paid by Encompass Health on July 15, 2026

Closing Share Price $109.88 Encompass Health common stock closing price on the July 15, 2026 dividend payment date

Shares Held After Transaction 49,643 shares Total Encompass Health shares directly held by Joan E. Herman following the RSU award

Key Terms

restricted stock units, dividend record date, closing price, non-employee director

4 terms

restricted stock units financial

"additional restricted stock units ("RSUs") are credited to each non-employee director's account"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

dividend record date financial

"number of the RSUs in each director's account on the associated dividend record date"

closing price financial

"divided by (b) the closing price on the dividend payment date"

non-employee director financial

"RSUs are credited to each non-employee director's account in connection with common stock dividend"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/16/2026 - 04:12 PM Accepted by SEC EDGAR 07/16/2026 - 04:12 PM Learn about SEC filing dates

FAQ

What did Encompass Health (EHC) director Joan E. Herman report in this Form 4?

Joan E. Herman reported an automatic acquisition of 85 RSUs tied to Encompass Health common stock. The award reflects dividend-equivalent RSUs credited under existing restricted stock unit agreements for non-employee directors.

How many Encompass Health (EHC) shares does Joan E. Herman hold after this transaction?

After the dividend-equivalent RSU award, Joan E. Herman directly holds 49,643 shares of Encompass Health common stock. This figure represents her direct ownership immediately following the July 15, 2026 transaction.

What triggered the 85 RSU award reported for Encompass Health (EHC)?

The 85 RSUs were credited in connection with a common stock dividend paid on July 15, 2026. Under outstanding RSU award agreements, non-employee directors receive additional RSUs when dividends are paid on Encompass Health common stock.

What were the dividend and share price used to calculate Joan E. Herman’s RSU credits at Encompass Health (EHC)?

The dividend-equivalent RSUs were based on a common stock dividend of $0.19 per share and a closing stock price of $109.88. These values on July 15, 2026 were used in the formula that credits additional RSUs.

Was Joan E. Herman’s Form 4 transaction for Encompass Health (EHC) an open-market purchase or a grant?

The transaction was a grant/award acquisition of 85 RSUs, coded “A” on Form 4. It reflects an automatic RSU credit tied to a dividend payment, not an open-market stock purchase or sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HERMAN JOAN E

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	07/15/2026		A		85(1)	A	$0	49,643	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.

	/s/ Patrick Darby, attorney-in-fact for Joan E. Herman	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)